6-sulfatoxymelatonin has been researched along with Macular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Cheng, XC; Feng, XP; Gao, QF; Gong, LL; Hu, L; Liu, S; Lv, XD; Wang, J; Xing, YQ; Yu, CH | 1 |
| Chen, M; Hu, DN; McCormick, SA; Perez, V; Rosen, R; Tai, K; Tone, P; Walsh, J; Yu, GP | 1 |
2 other study(ies) available for 6-sulfatoxymelatonin and Macular Degeneration
| Article | Year |
|---|---|
Correlation between serum melatonin and aMT6S level for age-related macular degeneration patients.
Topics: Aged; Case-Control Studies; Female; Humans; Macular Degeneration; Male; Melatonin; Middle Aged; Odds Ratio; Risk Factors | 2016 |
Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.
Topics: Aged; Aging; Case-Control Studies; Creatinine; Demography; Female; Humans; Macular Degeneration; Male; Melatonin | 2009 |